Invesco Ltd. - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 117 filers reported holding EDITAS MEDICINE INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 1.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2024$408,405
-36.7%
87,453
+0.6%
0.00%
Q1 2024$645,251
-29.6%
86,961
-3.9%
0.00%
Q4 2023$916,289
+42.1%
90,453
+9.4%
0.00%
Q3 2023$644,803
-2.3%
82,667
+3.1%
0.00%
Q2 2023$659,931
+15.5%
80,186
+1.7%
0.00%
Q1 2023$571,489
+15.5%
78,826
+41.3%
0.00%
Q4 2022$494,725
-27.8%
55,775
-0.4%
0.00%
Q3 2022$685,000
+0.3%
56,002
-3.1%
0.00%
Q2 2022$683,000
-36.2%
57,792
+2.8%
0.00%
Q1 2022$1,070,000
+13.6%
56,201
+58.4%
0.00%
Q4 2021$942,000
-40.2%
35,489
-7.5%
0.00%
Q3 2021$1,576,000
-17.0%
38,356
+14.4%
0.00%
Q2 2021$1,899,000
+106.6%
33,518
+53.2%
0.00%
Q1 2021$919,000
-67.1%
21,877
-45.0%
0.00%
-100.0%
Q4 2020$2,790,000
+685.9%
39,797
+214.8%
0.00%
Q3 2020$355,000
-6.1%
12,641
-1.1%
0.00%
Q2 2020$378,000
+38.0%
12,782
-7.8%
0.00%
Q1 2020$274,000
-12.7%
13,859
+30.7%
0.00%
Q4 2019$314,000
+22.2%
10,607
-6.2%
0.00%
Q3 2019$257,000
-11.7%
11,308
-3.8%
0.00%
Q2 2019$291,000
-2.0%
11,752
-3.4%
0.00%
Q1 2019$297,000
-64.8%
12,166
-67.2%
0.00%
Q4 2018$843,000
-89.4%
37,058
-88.8%
0.00%
-100.0%
Q3 2017$7,960,000331,5470.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2017
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 185,668$5,908,0004.56%
ARK Investment Management 2,793,854$88,900,0002.69%
Elmwood Wealth Management, Inc. 94,067$2,993,212,0002.48%
JS Capital Management LLC 218,935$6,967,0001.92%
Casdin Capital, LLC 460,000$14,637,0001.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,158,841$36,874,0001.32%
Valiant Capital Management, L.P. 379,800$12,085,0001.07%
Castle Rock Wealth Management, LLC 16,315$442,0000.70%
Capital Impact Advisors, LLC 57,406$1,861,0000.64%
Global Thematic Partners, LLC 481,568$15,323,0000.60%
View complete list of EDITAS MEDICINE INC shareholders